Experts
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on CSL.
RELATED STOCKHEAD STORIES
Closing Bell: Super Sigma lifts benchmark after oil saps energy stocks
News
ASX Small Cap Lunch Wrap: Oh what a CPI! Inflation elation as local markets jump on weak October prices
Health & Biotech
ScoPo’s Powerplays: Could ASX health stocks up for third week be a start of a Christmas rally?
Experts
Kyle on Capital: Three easy ASX picks for when you finally yield to Mr Bond
Experts
Life of Brian: Weighting for opportunity
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: Yoga = chill. Fact. And ASX health stocks up for second week
News
ASX Small Cap Lunch Wrap: Healthcare stocks lead some frankly marvellous ASX gains on Thursday
News
ASX Large Caps: CSL, Resmed, and Westpac led gainers; data shows Aussie economy is softening
Health & Biotech
ScoPo’s Powerplays: Who fancies a ‘MedWalk intervention’? Oh, and ASX healthcare stocks can’t catch a break
Experts
CRITERION: The pressure is on these ASX companies as they face the Annual General Music this week
News
ASX Large Caps: ASX drops further on war concerns, Treasury Wine rallies on China news
News
ASX Small Caps Lunch Wrap: Who got the worst kind of welcome home last week?
Experts
SUNDAY ROAST: The stocks that lit a fire under our experts this week
Health & Biotech
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
News
Traders’ Diary: A week of War, Worry and Wall Street earnings
News
ASX Large Caps: Shares snap five-day winning streak, CSL up on dip buying, Fletcher denies selling faulty products
Health & Biotech